WallStSmart

GE HealthCare Technologies Inc. (GEHC)vsIradimed Co (IRMD)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

GE HealthCare Technologies Inc. generates 24508% more annual revenue ($20.63B vs $83.81M). IRMD leads profitability with a 26.8% profit margin vs 10.1%. GEHC appears more attractively valued with a PEG of 1.70. IRMD earns a higher WallStSmart Score of 60/100 (C).

GEHC

Buy

60

out of 100

Grade: C+

Growth: 4.0Profit: 7.0Value: 7.3Quality: 4.3
Piotroski: 2/9Altman Z: 1.34

IRMD

Buy

60

out of 100

Grade: C

Growth: 8.0Profit: 9.5Value: 2.0Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

GEHCSignificantly Overvalued (-156.0%)

Margin of Safety

-156.0%

Fair Value

$30.94

Current Price

$72.20

$41.26 premium

UndervaluedFair: $30.94Overvalued
IRMDSignificantly Overvalued (-26.7%)

Margin of Safety

-26.7%

Fair Value

$81.34

Current Price

$101.78

$20.44 premium

UndervaluedFair: $81.34Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

GEHC2 strengths · Avg: 8.5/10
Return on EquityProfitability
22.4%9/10

Every $100 of equity generates 22 in profit

P/E RatioValuation
15.6x8/10

Attractively priced relative to earnings

IRMD5 strengths · Avg: 8.8/10
Operating MarginProfitability
31.3%10/10

Strong operational efficiency at 31.3%

Return on EquityProfitability
24.8%9/10

Every $100 of equity generates 25 in profit

Profit MarginProfitability
26.8%9/10

Keeps 27 of every $100 in revenue as profit

Revenue GrowthGrowth
17.0%8/10

17.0% revenue growth

EPS GrowthGrowth
24.8%8/10

Earnings expanding 24.8% YoY

Areas to Watch

GEHC4 concerns · Avg: 2.8/10
PEG RatioValuation
1.704/10

Expensive relative to growth rate

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

EPS GrowthGrowth
-17.7%2/10

Earnings declined 17.7%

Altman Z-ScoreHealth
1.342/10

Distress zone — elevated risk

IRMD4 concerns · Avg: 2.8/10
Price/BookValuation
13.8x4/10

Trading at 13.8x book value

Market CapQuality
$1.30B3/10

Smaller company, higher risk/reward

PEG RatioValuation
4.462/10

Expensive relative to growth rate

P/E RatioValuation
58.2x2/10

Premium valuation, high expectations priced in

Comparative Analysis Report

WallStSmart Research

Bull Case : GEHC

The strongest argument for GEHC centers on Return on Equity, P/E Ratio.

Bull Case : IRMD

The strongest argument for IRMD centers on Operating Margin, Return on Equity, Profit Margin. Profitability is solid with margins at 26.8% and operating margin at 31.3%. Revenue growth of 17.0% demonstrates continued momentum.

Bear Case : GEHC

The primary concerns for GEHC are PEG Ratio, Piotroski F-Score, EPS Growth.

Bear Case : IRMD

The primary concerns for IRMD are Price/Book, Market Cap, PEG Ratio. A P/E of 58.2x leaves little room for execution misses.

Key Dynamics to Monitor

GEHC profiles as a value stock while IRMD is a growth play — different risk/reward profiles.

GEHC carries more volatility with a beta of 1.18 — expect wider price swings.

IRMD is growing revenue faster at 17.0% — sustainability is the question.

GEHC generates stronger free cash flow (917M), providing more financial flexibility.

Bottom Line

GEHC scores higher overall (60/100 vs 60/100). Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

GE HealthCare Technologies Inc.

HEALTHCARE · MEDICAL DEVICES · USA

GE HealthCare Technologies Inc. provides medical technology, pharmaceutical diagnostics, and digital solutions in the United States. The company is headquartered in Chicago, Illinois.

Iradimed Co

HEALTHCARE · MEDICAL DEVICES · USA

IRADIMED CORPORATION develops, manufactures, markets and distributes magnetic resonance imaging (MRI) compatible medical devices and related accessories and services in the United States and internationally. The company is headquartered in Winter Springs, Florida.

Want to dig deeper into these stocks?